Clinical Trial Update: Liposomal Bupivacaine in Shoulder Arthroscopy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating liposomal bupivacaine for shoulder arthroscopy in rotator cuff tears was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Pennsylvania | Conditions: Rotator Cuff Tears | Phase 3 | Status: WITHDRAWN